-
Posted: February 8th, 2012, 3:00am CST
Edward Mills of the University of Ottawa, Canada and colleagues argue in this week's PLoS Medicine that the HIV/AIDS response in Africa needs a more balanced approach to gender, so that both men and women are involved in HIV treatment and prevention...
-
Posted: February 7th, 2012, 12:00pm CST
President, Founder and CEO of Black AIDS Institute, Phill Wilson, released a letter in light of the 12th annual National Black HIV/AIDS Awareness Day, stating that the Institute will be releasing their 8th annual State of AIDS in Black America Report. He comments that "It will highlight a reality that would have been unthinkable not long ago...
-
Posted: February 7th, 2012, 3:00am CST
The great paradox of global health efforts is that regions of the world most plagued by poverty, poor infrastructure and rampant disease are often the most difficult to deliver care to...
-
Posted: February 6th, 2012, 2:00am CST
According to a new analysis of hundreds of recorded office visits, doctors and nurse practitioners typically issued orders and asked closed or leading questions when talking to their HIV-positive patients about adherence to antiretroviral therapy. Attempts at problem-solving with patients who had lapsed occurred in less than a quarter of visits. Take your medicine, Doctor's orders...
-
Posted: February 2nd, 2012, 3:00am CST
ONCOLOGY: Answers to age-old questions surrounding fat cell cancer Myxoid round cell liposarcoma (MRCLS) is a cancerous tumor that typically arises in deep fat tissues of the limbs or abdomen. It was shown almost 20 years ago to be characterized by a chromosomal change that generates a fusion protein known as TLS:CHOP...
-
Posted: January 31st, 2012, 2:00pm CST
Health authorities in South Africa have recalled more than a million condoms that were handed out in the lead up to the African National Congress centenary celebrations...
-
Posted: January 29th, 2012, 2:00am CST
Using a combination of evolutionary biology and virology, scientists at Fred Hutchinson Cancer Research Center have traced the birth of the ability of some HIV-related viruses to defeat a newly discovered cellular-defense system in primates. The research, led by Michael Emerman, Ph.D., a member of the Hutchinson Center's Human Biology and Basic Sciences Division, and Harmit Malik, Ph.D...
-
Posted: January 27th, 2012, 11:00am CST
HIV-positive mothers can protected their babies from becoming infected with the virus if they take antiretroviral drugs during pregnancy. However, even though these drugs prevent transmitting the disease to the child, they could potentially cause birth defects like cleft lip and palate...
-
Posted: January 27th, 2012, 6:00am CST
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Treating head and neck cancer in HIV-positive patients is a challenge for oncologists...
-
Posted: January 26th, 2012, 2:00am CST
A saliva test used to diagnose the human immunodeficiency virus (HIV), is comparable in accuracy to the traditional blood test, according to a new study led by the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University...
-
Posted: January 25th, 2012, 2:00am CST
A spoonful of medicine goes down a lot easier if there is a dog or cat around. Having pets is helpful for women living with HIV/AIDS and managing their chronic illness, according to a new study from the Frances Payne Bolton School of Nursing at Case Western Reserve University. "We think this finding about pets can apply to women managing other chronic illnesses," said Allison R...
-
Posted: January 23rd, 2012, 3:00am CST
While global attention to HIV/AIDS remains strong, a lack of focus on prevention strategies is stonewalling health experts in many developing nations, specifically in the Caribbean...
-
Posted: January 20th, 2012, 10:00am CST
According to a study published in the current issue of the journal Cancer Prevention Research, aspirin should be assessed for its ability to prevent cervical cancer developing in women infected with HIV. Aspirin has the potential to provide considerable benefit for women in Africa, the Caribbean and Latin America, regions where death rates from cervical cancer are extremely high...
-
Posted: January 20th, 2012, 3:00am CST
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women...
-
Posted: January 17th, 2012, 5:00am CST
1. High Doses of Vitamin D Provide No Benefit to Patients with Severe COPD Chronic obstructive pulmonary disease (COPD) is one of the top 10 leading causes of morbidity and mortality in the United States. Vitamin D deficiency is present in 60 percent to 75 percent of patients with severe COPD...
-
Posted: January 13th, 2012, 3:00am CST
The level of HIV-1 in the blood of an HIV-infected partner is the single most important factor influencing risk of sexual transmission to an uninfected partner, according to a multinational study of heterosexual couples in sub-Saharan Africa...
-
Posted: January 12th, 2012, 11:00am CST
Raltegravir, an antiretroviral medication that delays the spread of HIV infection provides a new method to treat HIV in children and adolescents. The drug was recently approved (December 21, 2011) by the Food and Drug Administration (FDA) for use with other antiretroviral drugs to treat children and teenagers between 2 to18 years of age with the disease...
-
Posted: January 11th, 2012, 3:00am CST
In this week's PLoS Medicine, Andrea Ciaranello of Massachusetts General Hospital, Boston, USA and colleagues find, using a simulation model, that implementation of the latest WHO PMTCT (prevention of mother to child transmission of HIV) guidelines must take place in conjunction with improving access to PMTCT programs, increasing retention of women in care, and supporting adher...
-
Posted: January 7th, 2012, 2:00am CST
New guidelines from the American Academy of Neurology will help physicians better choose seizure drugs for people on HIV/AIDS medication, avoiding deadly drug interactions and preventing critical anti-HIV drugs from becoming less effective, possibly leading to a more virulent strain of the disease...
-
Posted: January 6th, 2012, 3:00pm CST
The US Centers for Disease Control and Prevention (CDC) has started handing out money to state and local health departments across the country to help fund high impact HIV prevention activities in 2012. The total amount of money available for 2012, intended to cover the first year of a five-year funding cycle, comes to $339 million, said the federal agency on Wednesday...
-
Posted: January 6th, 2012, 4:00am CST
Scientists have tested a trial vaccine that protects rhesus monkeys against infection from a potent form of the simian immunodeficiency virus (SIV), a distant relative of HIV, the virus that causes AIDS in humans. Monkeys that received the vaccine were more than 80% less likely to become infected when exposed to SIV than monkeys that received a dummy shot...
-
Posted: January 4th, 2012, 4:00am CST
New research published in the Journal of Leukocyte Biology suggests that high levels of estradiol present prior to ovulation decreases immune system effectiveness resulting in growth and promotion of infection A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection...
-
Posted: January 3rd, 2012, 3:00am CST
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. HPTN 052 evaluated whether antiretroviral drugs can prevent sexual transmission of HIV among couples in which one partner has HIV and the other does not...
-
Posted: January 3rd, 2012, 3:00am CST
Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment...
-
Posted: January 3rd, 2012, 2:00am CST
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects-work that may reveal new ways to design future HIV/AIDS drugs...
-
Posted: January 2nd, 2012, 2:00am CST
Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV-the virus that causes AIDS-hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic. Dr...
-
Posted: January 1st, 2012, 2:00am CST
In the first clinical trial of an injectable vaccine containing trimeric HIV envelope protein (gp140) relevant to the predominant strain of HIV in Africa, researchers from four UK academic centers (St George's University London, Imperial College, Hull York Medical School (HYMS; University of York) and the Medical Research Council Clinical Trial Unit) and from the Infectious Dis...
-
Posted: December 31st, 2011, 2:00am CST
Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a row that Science selected a trial for which FHI 360 provided scientific leadership and operational support...
-
Posted: December 28th, 2011, 2:00am CST
Gay men are able to lead healthier, less stress-filled lives when states offer legal protections to same-sex couples, according to a new study examining the effects of the legalization of same-sex marriage in Massachusetts...
-
Posted: December 27th, 2011, 3:00am CST
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects work that may reveal new ways to design future HIV/AIDS drugs...
-
Posted: December 26th, 2011, 2:00am CST
Human tumor viruses contribute to 15-20% of human cancers worldwide. Kaposi's sarcoma herpesvirus (KSHV) is an etiological agent for Kaposi's sarcoma (KS) and two other rare lymphoproliferative malignancies. KS is the most common cancer in HIV-infected untreated individuals and remains a primary cause of cancer deaths in many subequatorial African countries as a result of the AIDS pandemic...
-
Posted: December 23rd, 2011, 3:00am CST
Elsevier's Journal of Clinical Virology in collaboration with the US Centers for Disease Control and Prevention (CDC) announced the publication of a special supplement entitled 'Update on HIV Diagnostic Testing Algorithms'. This timely supplement contains articles which summarize studies since the 2010 US HIV Diagnostics Conference validating the proposed new US HIV diagnostic testing algorithm...
-
Posted: December 23rd, 2011, 3:00am CST
The finding of a team of researchers including several members from Johns Hopkins that HIV treatment with antiretroviral drugs (ARVs) can actually prevent transmission of the virus from an infected person to his or her uninfected partner has been named "Breakthrough of the Year" for 2011 by the journal Science...
-
Posted: December 23rd, 2011, 3:00am CST
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. HPTN 052 evaluated whether antiretroviral drugs can prevent sexual transmission of HIV among couples in which one partner has HIV and the other does not...
-
Posted: December 22nd, 2011, 5:00pm CST
The journal Science has named research led by Myron S. Cohen, MD., of the University of North Carolina at Chapel Hill, as the 2011 Scientific Breakthrough of the Year. The program, known as the HIV Prevention Trials Network 052 study looked into whether antiretroviral drugs can prevent the transmission of HIV amongst couples where only one partner has HIV...
-
Posted: December 22nd, 2011, 12:00pm CST
The US Food and Drug Administration has announced that it approves the expanded use of an important anti viral drug used to treat HIV infections. Isentress is an antiretroviral drug produced my Merck & Co. It was first approved in October 2007 and was the first of a new class of anti HIV drugs known as integrase inhibitors...
-
Posted: December 22nd, 2011, 3:00am CST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the ADAP Crisis Task Force (ACTF) announced a number of new initiatives to help struggling state AIDS Drug Assistance Programs (ADAPs) continue to provide access to medicines to people living with HIV...
-
Posted: December 22nd, 2011, 2:00am CST
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ (Canadian Medical Association Journal)...
-
Posted: December 20th, 2011, 2:00am CST
Among people recently infected with HIV, immediate antiretroviral therapy (ART) appears preferable to deferring treatment, according to a new study published in the Journal of Infectious Diseases and now available online. Although the benefits of ART during early HIV-1 infection remain unproven, the findings support growing evidence favoring earlier ART initiation...
-
Posted: December 19th, 2011, 2:00am CST
Behavioral interventions aimed at reducing sexual risk behaviors, such as unprotected sex, are effective at both promoting condom use and reducing sexually transmitted infections (STIs) long after the initial intervention, according to a new report in the Journal of Acquired Immune Deficiency Syndromes. Lead author Lori A. J. Scott-Sheldon, Ph.D...
-
Posted: December 16th, 2011, 2:00am CST
Chronic infections by viruses such as HIV or hepatitis C eventually take hold because they wear the immune system out, a phenomenon immunologists describe as exhaustion. Yet exhausted immune cells can be revived after the introduction of fresh cells that act like coaches giving a pep talk, researchers at Emory Vaccine Center have found...
-
Posted: December 16th, 2011, 2:00am CST
Developed countries and funding agencies are putting the brakes on growth in development assistance for health, raising the possibility that developing countries will have an even harder time meeting the Millennium Development Goal deadline looming in 2015, according to new research from the Institute for Health Metrics and Evaluation at the University of Washington...
-
Posted: December 16th, 2011, 2:00am CST
Scientists at the Gladstone Institutes have discovered new protein fragments in semen that enhance the ability of HIV, the virus that causes AIDS, to infect new cells - a discovery that one day could help curb the global spread of this deadly pathogen. HIV/AIDS has killed more than 25 million people around the world since first being identified some 30 years ago...
-
Posted: December 15th, 2011, 2:00am CST
An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according to new research from the Perelman School of Medicine at the University of Pennsylvania that was presented at the 53rd American Society of Hematology Annual Meeting...
-
Posted: December 14th, 2011, 2:00am CST
A study from Rhode Island Hospital is the first to systematically review and analyze the literature on the association between HIV infection and overdose risk. The findings show a 74 percent greater risk of overdose among drug users if they are HIV-infected...
-
Posted: December 13th, 2011, 3:00am CST
IMMUNOLOGY: Finding a new immune function for NEMO Ectodermal dysplasias are a group of inherited conditions in which there is abnormal development and function of the skin, hair, nails, teeth, and/or sweat glands. Individuals with ectodermal dysplasia with immune deficiency (EDI) also have a dysfunctional immune system that renders them susceptible to severe infections...
-
Posted: December 12th, 2011, 11:00pm CST
A new study shows the more a person drinks, the stronger their intention becomes to have unsafe sex. The spread of the HIV virus is mainly caused by unsafe sex and it is a major risk factor for the global burden of disease...
-
Posted: December 12th, 2011, 3:00am CST
Global HIV/AIDS prevention and treatment efforts are missing a major opportunity to significantly improve health conditions in poor countries by simply adding low-cost care for the many other chronic and disabling diseases routinely afflicting and often killing these same patients, according to a panel of disease experts who spoke at the annual meeting of the American Society o...
-
Posted: December 11th, 2011, 2:00am CST
Scientists have found the 'key' that HIV uses to enter our cells' nuclei, allowing it to disable the immune system and cause AIDS The finding, published today in the open access journal PLoS Pathogens, provides a potential new target for anti-AIDS drugs that could be more effective against drug-resistant strains of the virus...
-
Posted: December 9th, 2011, 2:00am CST
A new weapon has emerged to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is a strategy of providing medications to at-risk people before they are exposed to the virus. Having shown great promise in recent phase 3 clinical trials, PrEP may soon be rolled out for public use...